pharmaphorum

DECEMBER 14, 2022

BehaVR is working on VR-enabled DTx for anxiety, stress, pain, and addiction, based on biometrics and machine learning, and these will complement OxfordVR’s pipeline led by gameChange , a virtual psychological therapy designed to provide active coaching to people with psychosis to help them manage anxieties associated with day-to-day life.

Pharma 95

Pharma Management FDA Patients 95

Pharmaceutical Technology

FEBRUARY 3, 2023

Under the deal, Karuna will have an exclusive worldwide licence for the development, manufacturing, and commercialisation of multiple Goldfinch Bio’s TRPC4/5 candidates, including GFB-887, the lead clinical-stage candidate. In preclinical models of mood and anxiety disorders, GFB-887 showed compelling benefits.

Sales 52

Sales Safety Leads Manufacturing 52

European Pharmaceutical Review

SEPTEMBER 20, 2022

Zuranolone is an investigational oral 14-day treatment under clinical development for adult patients with MDD and postpartum depression. Zuranolone was generally well-tolerated with a safety profile consistent with prior clinical studies.

Safety 88

Safety Patients Leads Pharmaceutical 88

Pharmaceutical Technology

JANUARY 22, 2024

Repurposed Drugs is under clinical development by Luminous Mind and currently in Phase I for Anxiety Disorders.

40

40

Pharmaceutical Technology

JANUARY 22, 2024

Repurposed Drugs is under clinical development by Luminous Mind and currently in Phase I for Anxiety Disorders.

40

40

pharmaphorum

SEPTEMBER 23, 2022

On Tuesday, Curebase announced a three-year clinical trial partnership with Meru Health, the study looking at the effectiveness of the latter’s 12-week treatment program, developed to reduce depression in primary care patients.

Recruitment 59

Recruitment Patients Electronics Doctors 59

European Pharmaceutical Review

MARCH 8, 2023

PureTech Health has announced it will advance its oral allopregnanolone candidate LYT-300, for the potential treatment of anxiety and postpartum depression (PPD). A placebo-controlled, Phase IIa, proof-of-concept, social anxiety clinical trial is expected to begin in the first half of 2023.

Transportation 91

Transportation Medical Pharmaceutical 91

pharmaphorum

OCTOBER 13, 2022

Swedish digital health company Alex Therapeutics has reported encouraging results in a trial of a digital therapeutic (DTx) for anxiety in patients with the respiratory disease idiopathic pulmonary fibrosis (IPF). The post Digital therapeutic cuts IPF-related anxiety by half in pilot study appeared first on.

Safety 59

Safety Patients Pharma Medical 59

pharmaphorum

SEPTEMBER 8, 2022

Asking patients with chronic conditions to regularly inject themselves can be challenging, causing needle anxiety and worry that they may not carry out the procedure correctly, which can reduce compliance. The post Ypsomed brings Sidekick on board to fight self-injection anxiety appeared first on.

Patients 105

Patients Marketing Pharma Medical 105

World of DTC Marketing

APRIL 25, 2022

Studies about the prevalence of anxiety that results from atrial fibrillation pings are hard to come by. It will take a while to get them right and develop clinical studies to support their use, but wearables are the future of patient-focused healthcare. Industry came out with these things because they could.

Doctors 231

Doctors Healthcare Healthcare Patients 231

Pharmacy Times

JANUARY 4, 2023

The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.

55

55

European Pharmaceutical Review

DECEMBER 15, 2022

The primary endpoint in both trials evaluated the proportion of patients with clinically meaningful improvement in itch from baseline (measured by a ≥4-point reduction in Worst-Itch Numeric Rating Scale [WI-NRS] on a 0-10 scale) at 24 and 12 weeks, respectively. Phase III trial data that formed the basis of the EC’s approval.

Medicine 83

Medicine Safety Side effects Patients 83

European Pharmaceutical Review

DECEMBER 13, 2022

North American psychedelic drug developers Mindset, PharmAla, Mydecine and Psyence have signed with clinical research organisation (CRO) Clerkenwell Health to trial therapies for mental health conditions, in London, UK, to benefit from the country’s swift drug regulatory process.

Medicine 101

Medicine Food and Drug Administration Ethics Government 101

World of DTC Marketing

APRIL 11, 2021

The CDC says “neither the recently authorized and recommended vaccines nor the other COVID-19 vaccines currently in clinical trials in the United States can cause you to test positive on viral tests , which are used to see if you have a current infection.? Plus, clinical trial settings aren’t always the same as real-world settings.

Pharmaceutical 303

Pharmaceutical Patients Sales 303

European Pharmaceutical Review

JUNE 26, 2023

US Food and Drug Administration (FDA) has published its first draft guidance presenting considerations to the pharmaceutical industry for designing clinical trials for psychedelic drugs. The draft guidance is intended to advise researchers on aspects such as clinical study design as they develop medications that contain psychedelics.

Food and Drug Administration 85

Food and Drug Administration FDA Safety Food 85

Pharmaceutical Technology

AUGUST 12, 2022

OxfordVR uses VR headsets to simulate real-world everyday scenarios for patients that are often associated with increased anxiety and stress. Clinical trials of gameChangerVR have been run with both the National Health Service (NHS) and the US veteran’s charity Wounded Warrior Project.

Food and Drug Administration 141

Food and Drug Administration Pharmacology Side effects Physicians 141

PM360

JUNE 16, 2023

1 When an individual is diagnosed with a rare disease, they often experience fear, uncertainty, and anxiety. Clinical trials are an invaluable component of new drug development. Despite this, nearly 80% of clinical trials fail to finish on schedule, with 20% delayed over six months or more. References: 1.

Patients 98

Patients Recruitment Medical Marketing 98

Pharmacy Times

SEPTEMBER 22, 2022

Research suggests that acupuncture may be able to clinically reduce symptoms of anxiety in this patient population.

Patients 49

Patients 49

PM360

DECEMBER 20, 2023

From direct peer consultation to private groups, to journal clubs, to following Digital Opinion Leaders (DOLs) social media has become part of an HCP’s clinical toolkit. HCPs are pressed for time, eager to keep up with scientific and clinical developments, skeptical about big pharma, and increasingly focused on outcomes and metrics.

Media 122

Media Physicians Pharma reps Pharma Rep 122

PM360

OCTOBER 25, 2023

A Plan of Action for State Regulators Right Now We know, clinically guided, science-based cannabis therapy has been proven to provide life-altering benefits for relief from symptoms such as cancer treatment, pain, anxiety, and sleep disorders. Let’s start by looking at what regulators could do now.

Food and Drug Administration 119

Food and Drug Administration FDA Insurance Medical 119

pharmaphorum

DECEMBER 19, 2022

” That could include musculoskeletal pain, mobility in older people, anxiety-related disorders and long COVID, according to the researchers. Ultimately, however, the plan is to develop a fully autonomous system that patients can use at home to reduce the time they are in clinics.

Patients 138

Patients Engineering Government Education 138

Penrod

JANUARY 16, 2024

The Answer: Automate Forms for Faster Results One of our largest clients, a clinician-guided clinic offering outpatient behavioral health across multiple US states, wanted to innovate their assessment processes. The post How Mental Health Clinics Automate Assessment Forms with Salesforce Health Cloud appeared first on Penrod.

Healthcare 52

Healthcare Healthcare Patients Engineering 52

PM360

AUGUST 9, 2022

As a result, anxiety abounds on many levels and failure to take the medication, or adhere properly, ensues. Such programs have demonstrated that 92% of patients enrolled in a support program and working with a clinical educator continue on their treatment versus 63% who don’t have a support program.

Education 59

Education Side effects Physicians Patients 59

pharmaphorum

NOVEMBER 15, 2022

Among those who partook in the survey, the most diagnosed chronic conditions they suffered from were anxiety (56%) and depression (52%), and chronic pain (26%), hypertension (24%), and migraine (22%). Of those who were afflicted by anxiety, 73% also battled with depression.

Education 117

Education Healthcare Provider Physicians Electronics 117

Pharmaceutical Technology

JUNE 5, 2023

Results unveiled at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting indicate that some patients with locally advanced rectal cancer can be treated with chemotherapy alone and may not need radiation therapy before surgery. Additionally, the patients had to be candidates for surgery. In the FOLFOX group, 9.1%

Patients 52

Patients Side effects Medicine 52

European Pharmaceutical Review

NOVEMBER 3, 2022

In total there are some 524 microbiome therapeutics – 48 percent in pre-clinical development and 42 percent in clinical development – with live biotherapeutics products dominating (177 therapeutics). For example, the design of clinical trials, the IP laws – how can you patent live microbial environments – and safety profiles.

Safety 84

Safety Patients Pharmaceutical Marketing 84

MedCity News

JUNE 16, 2023

And in the first quarter of this year, the largest Series A ever in digital health ($203M) went into a company accelerating clinical trials and drug development. Numerous clinical, regulatory and financial factors are behind this digital shift in pharma. accelerating time to drug availability by more than a year in one case.

Pharma 119

Pharma Food and Drug Administration Recruitment Pharmacology 119

Clarify Health

MAY 18, 2023

It leverages Clarify’s data assets, including claims, clinical, and social determinants of health data across 300 million patient journeys to shine a light on important healthcare issues and explore trends.

Media 52

Media Healthcare Healthcare Insurance 52

World of DTC Marketing

MARCH 27, 2022

Psychologists reported the most significant increases in treating anxiety disorders (84%, up from 74%), depressive disorders (72%, up from 60%), and trauma- and stress-related conditions (62%, up from 50%). Switzerland allows anyone, for any reason, to request assisted suicide via a clinic. There was a 0.3%

Healthcare 259

Healthcare Healthcare Insurance Ethics 259

Medgadget

JUNE 13, 2022

Blood pressure is a crucial factor in cardiovascular health, but measuring it using conventional pressurized cuff systems in a doctor’s clinic is prone to unreliable results. However, patients can also be prone to “white coat syndrome,” where anxiety during such measurements can lead to significantly misleading results.

Medical 85

Medical Patients Doctors Manufacturing 85

Eversana Intouch

JANUARY 19, 2023

It’s especially important in categories adopting metaverse efforts early, such as mental health (PTSD, anxiety, depression), neurology (ADHD, MS, pain management), and procedure-driven specialties like surgery. Evaluate potential synergies and partnerships with digital therapeutics.

Medical 52

Medical Education Competition Marketing 52

Pharmaceutical Technology

APRIL 20, 2023

It works by restoring glucagon secretion, changing the management of diabetes and helping to improve patients’ health and quality of life.

Food and Drug Administration 52

Food and Drug Administration FDA Food Patients 52

pharmaphorum

OCTOBER 21, 2022

DJS’ co-founders, David Llewellyn and Joe Illingworth said: “DJS was built on the principles of scientific curiosity and an aspiration to discover clinically meaningful innovative medicines. DJS is backed by founding investors Oxford Science Enterprises and Johnson & Johnson Innovation Ltd.,

Side effects 59

Side effects Medicine Medical Patients 59

Medgadget

MAY 2, 2023

During this time, two additional studies ended successfully and were published, further validating the clinical safety and effectiveness. The product will be available in the US this year as a prescription device, designed to fit into any clinic, administered under the direction of mental healthcare professionals.

Side effects 87

Side effects Prescription Healthcare Healthcare 87

European Pharmaceutical Review

MARCH 11, 2024

They often arise when taking daily pills, causing fear of HIV status disclosure, stress and anxiety about staying adherent, and the constant reminder that the individual is living with HIV. Having clinical trial designs focused on diversity is important. 3 But that paradigm is rapidly changing.

Medicine 92

Medicine Pharmacology Healthcare Healthcare 92

pharmaphorum

NOVEMBER 2, 2022

Siva Nadarajah, president and co-founder of Jogo Health, explained to pharmaphorum how the digital therapeutic operates: “Jogo-Gx uses wearable sensors and an AI-based app to help patients break the pain-anxiety-muscle tension cycle through the process of neuroplasticity.

Food and Drug Administration 126

Food and Drug Administration Food FDA Patients 126

Legacy MEDSearch

FEBRUARY 8, 2023

TargetCool has been proven to provide temporary analgesia to the skin for needle-based procedures in aesthetics such as Dermal Fillers, Toxin, and PRP injections, thus elevating patient comfort and reducing pain-related anxiety. TargetCool can also reduce bruising, inflammation, and swelling post-procedure.

Management 98

Management Medical Marketing FDA 98